Holly Scott & David Kuraguntla l Pivoting in Technology Development

The journey of mission, technology, market, and team development in a startup is the foundation […]

The journey of mission, technology, market, and team development in a startup is the foundation of a successful company. It isn’t uncommon for one of these pillars, technology, to initially run in a different direction.

David Kuraguntla, CEO of Alio, shared how challenging it was to pivot his team from an implantable smart sensor design to an external wearable. David shared that keeping the 4P’s in mind, “Patient, Physician, Provider and Payer”, and taking a bet on themselves, created the platform towards their first potassium remote monitoring platform, winning FDA approval and is commercially available.

With over 35 million adults living with chronic kidney disease, CKD, and another large percentage of the population unaware they have it, addressing kidney disease is not only important to our health, it is seen as one of the largest emerging frontiers with its multibillion dollar market potential.

In kidney disease, the body has trouble removing surplus potassium from the blood. This causes potassium levels to rise, which can lead to problems with other major organs including the heart. David Kuraguntla explains that we “Don’t think about kidney enough” and how Alio’s smartpatch is working to help manage this patient population with more actionable information, while empowering the patient with more control and peace of mind.

Thank you David Kuraguntla for the conversation, and the important work you and the team are doing at Alio. Check out our full discussion.